Company Filing History:
5 out of 21 
1 out of 1 Years Active: 2021-2025
Title: Christie Munn: Innovator in Immune Cell Therapy
Introduction
Christie Munn is a prominent inventor based in Madison, WI (US), known for her significant contributions to the field of immunology. With a total of four patents to her name, she has made remarkable strides in the development of antigen-specific immune effector cells and methods for directed differentiation of pluripotent stem cells.
Latest Patents
One of Christie Munn's latest patents focuses on "Antigen-specific immune effector cells." This patent outlines methods for producing antigen-specific effector T cells and NK cells from pluripotent stem cells that express a chimeric antigen receptor (CAR). Additionally, it provides methods for adoptive cell therapy by administering these effector T cells and/or NK cells. Another significant patent is titled "Methods for directed differentiation of pluripotent stem cells to immune cells." This patent describes efficient in vitro differentiation techniques for somatic cell-derived pluripotent stem cells into hematopoietic precursor cells, which can further differentiate into various immune cells, including T cells, NK cells, and dendritic cells. Notably, these pluripotent cells can be maintained and differentiated under defined conditions, eliminating the need for mouse feeder cells or serum in certain embodiments.
Career Highlights
Christie Munn is currently employed at Fujifilm Cellular Dynamics, Inc., where she continues to advance her research in immune cell therapies. Her work has been instrumental in developing innovative solutions that could potentially transform treatment methodologies in immunology.
Collaborations
Some of her notable coworkers include Deepika Rajesh and Bradley Swanson, who contribute to the collaborative environment that fosters innovation and research excellence.
Conclusion
Christie Munn's work in the field of immunology, particularly in the development of immune effector cells and pluripotent stem cell differentiation, showcases her dedication to advancing medical science. Her patents reflect a commitment to improving therapeutic options for patients, highlighting her role as a key innovator in this vital area of research.